About the Role

This is a zero-to-one growth role at an early-stage healthtech company building AI-powered reimbursement automation for interventional specialties. You will own the full go-to-market motion for medical device OEMs, from defining the ideal customer profile to closing the first enterprise accounts, working directly with the founding team to shape revenue and product-market fit.

What You'll Do

• Source OEM leads and build relationships across market access and reimbursement teams.

• Run discovery sessions to map OEM workflows and identify where the platform adds value.

• Develop a clear ideal customer profile and build a repeatable sales playbook from scratch.

• Own OEM accounts end-to-end, from first call through signed contract and ongoing expansion.

• Attend key industry conferences and develop community partnerships to grow reach.

• Research opportunities across procurement, market access intelligence, and reimbursement infrastructure.

• Partner cross-functionally to translate OEM needs into product and commercialization priorities.

What We're Looking For

• 4 to 7 years of experience working in or closely with medical device companies.

• Direct experience in reimbursement, market access, or health economics outcomes research.

• Strong understanding of the OEM ecosystem, including how reimbursement risk affects commercial and procurement decisions.

• Experience in endovascular, cardiovascular, or interventional radiology specialties is strongly preferred.

• Cross-functional exposure spanning market access, reimbursement, supply chain, and R&D.

• Comfortable actively incorporating AI tools into your daily workflow.

• Based in the United States; New York City is ideal but candidates located elsewhere in the US are welcome to apply.

• Willingness to travel to conferences and meet with partners in person as needed.

Compensation & Benefits

Base salary range: $130,000 to $200,000 USD annually, plus meaningful equity. Visa sponsorship is not available for this role.

Location

Hybrid, with a primary base in New York City, New York, United States. Some travel to industry conferences is expected.